Drug Trial Radar · NCT02422940
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
Last checked: Nov 20, 2026Latest source record: Jan 22, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
294
Actual
Start
Apr 2015
Primary completion
Jan 2017
Study completion Jan 2017
Sponsor
- Lead sponsor
- Acorda TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Apr 22, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an extension study to evaluate the long-term safety, tolerability, and efficacy of two dose strengths of dalfampridine-ER.
Conditions
- Post-ischemic Stroke
Interventions
dalfampridine-ER 7.5 mgDrug
dalfampridine-ER 10 mgDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Primary Objective Was to Evaluate Serious and Non-serious Adverse Events for Study Participants as a Measure of Safety and Tolerability of Dalfampridine ER (Extended Release) for at Least 12-months.Time frame: up to 12 months
Locations
66 sites in 2 countries. Site status is shown where the registry gives one.
Acorda Site #117
Gilbert, Arizona
Acorda Site #109
Berkeley, California
Acorda Site #170
Carlsbad, California
Acorda Site #138
Long Beach, California
Acorda Site #105
Newport Beach, California
Acorda Site #142
Pasadena, California
Acorda Site #153
Sacramento, California
Acorda Site #151
San Diego, California
Acorda Site #163
San Diego, California
Acorda Site #124
Colorado Springs, Colorado
Acorda Site #110
Danbury, Connecticut
Acorda Site #149
Fairfield, Connecticut
Acorda Site #130
Stamford, Connecticut
Acorda Site #115
Atlantis, Florida
Acorda Site #119
Deerfield Beach, Florida
Acorda Site #147
Gainesville, Florida
Acorda Site #128
Hialeah, Florida
Acorda Site #184
Jacksonville, Florida
Acorda Site #103
Miami, Florida
Acorda Site #133
Miami, Florida
Acorda Site #161
Naples, Florida
Acorda Site #106
Tampa, Florida
Acorda Site #181
Honolulu, Hawaii
Acorda Site #171
Chicago, Illinois
Acorda Site #148
Avon, Indiana
Acorda Site #188
Fort Wayne, Indiana
Acorda Site #156
Franklin, Indiana
Acorda Site #146
Lexington, Kentucky
Acorda Site #150
New Orleans, Louisiana
Acorda Site #175
Fulton, Maryland
Acorda Site #136
Boston, Massachusetts
Acorda Site #121
Boston, Massachusetts
Acorda Site #123
East Lansing, Michigan
Acorda Site #164
Farmington Hills, Michigan
Acorda Site #159
Grand Rapids, Michigan
Acorda Site #101
Kansas City, Missouri
Acorda Site #111
Great Falls, Montana
Acorda Site #140
Reno, Nevada
Acorda Site #131
New Brunswick, New Jersey
Acorda Site #177
Stratford, New Jersey
Showing 40 of 66 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.